NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · page 26 of 33
The slide outlines the methodology for a Phase 2 clinical trial for Alzheimer's Disease (AD).
Pitch deck · appendix_methodology · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 image 1/1 list 1/1 title 2/2
Components 5
process logo bullet action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1